• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

含氮和氧的五元芳环在调节胆汁酸受体中的作用:综述。

The Role of Five-Membered Aromatic Rings Containing N and O in Modulating Bile Acid Receptors: An Overview.

作者信息

Finamore Claudia, Festa Carmen, Barbato Rosa, Fiorucci Stefano, Zampella Angela, De Marino Simona

机构信息

Department of Pharmacy, University of Naples Federico II, Via Domenico Montesano 49, Naples, 80131, Italy.

Department of Medicine and Surgery, University of Perugia, Piazza L. Severi, 1, Perugia, 06132, Italy.

出版信息

ChemMedChem. 2025 Aug 16;20(16):e202500405. doi: 10.1002/cmdc.202500405. Epub 2025 Jul 11.

DOI:10.1002/cmdc.202500405
PMID:40536013
Abstract

Over the past decades, extensive scientific research in the fields of chemistry and pharmaceutical chemistry has led to the synthesis and study of numerous chemical compounds with diverse therapeutic applications. Many of these compounds feature heterocyclic aromatic structures, including four-, five-, and six-membered rings. Among them, five-membered heteroaromatic rings have garnered particular attention in medicinal chemistry due to their favorable properties, such as enhanced metabolic stability, solubility, and bioavailability, key attributes for the development of effective drugs. The distinctive physicochemical properties and biological activities of five-membered heterocycles have established them as vital structural motifs in numerous clinically effective drugs. These heterocyclic compounds play a crucial role in the design of therapeutic agents, including those targeting bile acid receptors. Bile acid receptor modulators, activated by endogenous bile acids, offer promising potential in treating a variety of metabolic and enterohepatic disorders, such as dyslipidemia, diabetes, cholestasis, and inflammatory bowel disease. This review aims to provide an up-to-date overview of aromatic five-membered nitrogen- and oxygen-containing heterocycles, focusing on their role as bile acid receptor modulators, particularly farnesoid X receptor and G protein-coupled bile acid receptor 1. These receptors are clinically validated targets for the treatment of metabolic disorders and nonalcoholic steatohepatitis.

摘要

在过去几十年中,化学和药物化学领域广泛的科学研究促使人们合成并研究了众多具有不同治疗应用的化合物。这些化合物中的许多都具有杂环芳香结构,包括四元、五元及六元环。其中,五元杂芳环因其良好的性质,如增强的代谢稳定性、溶解性和生物利用度(这些都是开发有效药物的关键属性),在药物化学中受到了特别关注。五元杂环独特的物理化学性质和生物活性使其成为众多临床有效药物中至关重要的结构基序。这些杂环化合物在治疗剂的设计中起着关键作用,包括那些靶向胆汁酸受体的药物。由内源性胆汁酸激活的胆汁酸受体调节剂在治疗多种代谢和肠肝疾病,如血脂异常、糖尿病、胆汁淤积和炎症性肠病方面具有广阔的潜力。本综述旨在提供关于芳香族五元含氮和含氧杂环的最新概述,重点关注它们作为胆汁酸受体调节剂的作用,特别是法尼酯X受体和G蛋白偶联胆汁酸受体1。这些受体是治疗代谢紊乱和非酒精性脂肪性肝炎的经临床验证的靶点。

相似文献

1
The Role of Five-Membered Aromatic Rings Containing N and O in Modulating Bile Acid Receptors: An Overview.含氮和氧的五元芳环在调节胆汁酸受体中的作用:综述。
ChemMedChem. 2025 Aug 16;20(16):e202500405. doi: 10.1002/cmdc.202500405. Epub 2025 Jul 11.
2
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
3
Management of urinary stones by experts in stone disease (ESD 2025).结石病专家对尿路结石的管理(2025年结石病专家共识)
Arch Ital Urol Androl. 2025 Jun 30;97(2):14085. doi: 10.4081/aiua.2025.14085.
4
Synthetic Approaches and Biological Significance of Four-Membered Heterocyclic Compounds.四元杂环化合物的合成方法及生物学意义
Curr Top Med Chem. 2025 Jul 23. doi: 10.2174/0115680266375132250715112753.
5
The Black Book of Psychotropic Dosing and Monitoring.《精神药物剂量与监测黑皮书》
Psychopharmacol Bull. 2024 Jul 8;54(3):8-59.
6
Caffeoylquinic acids from Silphium perfoliatum L. show hepatoprotective effects on cholestatic mice by regulating enterohepatic circulation of bile acids.来自美洲 Silphium perfoliatum L. 的咖啡酰奎宁酸通过调节胆汁酸的肠肝循环对胆汁淤积小鼠显示出肝保护作用。
J Ethnopharmacol. 2025 Jan 30;337(Pt 2):118870. doi: 10.1016/j.jep.2024.118870. Epub 2024 Sep 30.
7
Latest developments in small molecule analgesics: heterocyclic scaffolds I.小分子镇痛药的最新进展:杂环骨架I。
Future Med Chem. 2025 Aug;17(15):1899-1918. doi: 10.1080/17568919.2025.2546783. Epub 2025 Aug 12.
8
1,2,4-Oxadiazoles in medicinal chemistry: trends of the last years.药物化学中的1,2,4-恶二唑:近年来的发展趋势。
Eur J Med Chem. 2025 Nov 5;297:117935. doi: 10.1016/j.ejmech.2025.117935. Epub 2025 Jul 5.
9
The gut microbiota-bile acid axis: a crucial regulator of immune function and metabolic health.肠道微生物群-胆汁酸轴:免疫功能和代谢健康的关键调节因子。
World J Microbiol Biotechnol. 2025 Jun 25;41(7):215. doi: 10.1007/s11274-025-04395-7.
10
Updates on Intrinsic Medicinal Chemistry of 1,4-dihydropyridines, Perspectives on Synthesis and Pharmacokinetics of Novel 1,4-dihydropyrimidines as Calcium Channel Blockers: Clinical Pharmacology.1,4 - 二氢吡啶的内在药物化学进展,新型1,4 - 二氢嘧啶作为钙通道阻滞剂的合成与药代动力学展望:临床药理学
Curr Top Med Chem. 2025 Jan 1. doi: 10.2174/0115680266323908241114064318.

本文引用的文献

1
Dual Modulator of FXR and HSD17B13: Revitalizing FXR Therapies in MASH.FXR和HSD17B13的双重调节剂:重振非酒精性脂肪性肝炎中的FXR疗法
J Med Chem. 2025 Mar 27;68(6):6104-6107. doi: 10.1021/acs.jmedchem.5c00539. Epub 2025 Mar 5.
2
Bile acid activated receptors: Integrating immune and metabolic regulation in non-alcoholic fatty liver disease.胆汁酸激活受体:整合非酒精性脂肪性肝病中的免疫与代谢调节
Liver Res. 2021 Sep 2;5(3):119-141. doi: 10.1016/j.livres.2021.08.003. eCollection 2021 Sep.
3
Discovery of First-in-Class FXR and HSD17B13 Dual Modulator for the Treatment of Metabolic Dysfunction-Associated Fatty Liver Disease.
发现用于治疗代谢功能障碍相关脂肪性肝病的一流法尼醇X受体(FXR)和17β-羟类固醇脱氢酶13(HSD17B13)双重调节剂
J Med Chem. 2025 Mar 27;68(6):6127-6148. doi: 10.1021/acs.jmedchem.4c02720. Epub 2025 Jan 24.
4
Design, synthesis, and biological evaluation of novel highly potent FXR agonists bearing piperidine scaffold.新型含哌啶骨架的高效FXR激动剂的设计、合成及生物学评价
Eur J Med Chem. 2025 Jan 15;282:117082. doi: 10.1016/j.ejmech.2024.117082. Epub 2024 Nov 19.
5
Design, Synthesis, and Pharmacological Evaluation of Dual FXR-LIFR Modulators for the Treatment of Liver Fibrosis.设计、合成及双重 FXR-LIFR 调节剂的药理学评价用于治疗肝纤维化。
J Med Chem. 2024 Oct 24;67(20):18334-18355. doi: 10.1021/acs.jmedchem.4c01651. Epub 2024 Oct 9.
6
Combinatorial Organic Synthesis Using Parke-Davis's DIVERSOMER Method.使用帕克-戴维斯公司的DIVERSOMER方法进行组合有机合成。
Acc Chem Res. 1996 Mar 13;29(3):114-122. doi: 10.1021/ar950209v.
7
Editorial: Five-membered heterocycles: synthesis and applications.社论:五元杂环:合成与应用
Front Chem. 2024 Jun 25;12:1445671. doi: 10.3389/fchem.2024.1445671. eCollection 2024.
8
Synthesis of 3,5-disubstituted isoxazoles by domino reductive Nef reaction/cyclization of β-nitroenones.通过多米诺还原内夫反应/β-硝基烯酮环化合成3,5-二取代异恶唑
Org Biomol Chem. 2024 Apr 24;22(16):3299-3303. doi: 10.1039/d4ob00232f.
9
Improvement of NASH and liver fibrosis through modulation of the gut-liver axis by a novel intestinal FXR agonist.通过新型肠道 FXR 激动剂调节肠-肝轴改善 NASH 和肝纤维化。
Biomed Pharmacother. 2024 Apr;173:116331. doi: 10.1016/j.biopha.2024.116331. Epub 2024 Mar 1.
10
Discovery of LH10, a novel fexaramine-based FXR agonist for the treatment of liver disease.LH10的发现,一种新型的基于非瑟胺的法尼酯X受体激动剂,用于治疗肝脏疾病。
Bioorg Chem. 2024 Feb;143:107071. doi: 10.1016/j.bioorg.2023.107071. Epub 2024 Jan 4.